Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion type Assertion NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_head.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion description "[Taken together our data suggests that EBBP acts to de-repress transcription of RARbeta2 and CYP26A1, by modifying histone acetylation in retinoid-resistant cancer cells, and, is an important target for drug discovery in retinoid-resistant cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_provenance.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion evidence source_evidence_literature NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_provenance.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion SIO_000772 19147277 NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_provenance.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion wasDerivedFrom befree-20140225 NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_provenance.
- NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_assertion wasGeneratedBy ECO_0000203 NP711430.RAKtQ_A4VSPlxRgBPS9YB7-rRMBSXhXCua2CZuYDUpIM4130_provenance.